Search research articles
Contact Us
Filters
Showing results (221-230 of 333) with videos related to
Page
of 34
Sort By:
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties
Qiyu Qiu, Fabienne Dudouit, Stephanie L Matheson, et al.
Journal of Vascular Surgery
|
November 1, 1994
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
K M Newman, J Jean-Claude, H Li, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
Suman Rao, Benoît Thibault, Lisa Peyrard, et al.
Chemical Biology & Drug Design
|
March 8, 2008
Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase
Anne-Laure Larroque, Brad Peori, Christopher Williams, et al.
Frontiers in Aging Neuroscience
|
December 21, 2020
Fornix Integrity Is Differently Associated With Cognition in Healthy Aging and Non-amnestic Mild Cognitive Impairment: A Pilot Diffusion Tensor Imaging Study in Thai Older Adults
Patcharaporn Srisaikaew, Nahathai Wongpakaran, Nicole D Anderson, et al.
Catheterization and Cardiovascular Diagnosis
|
May 1, 1994
High incidence of renal artery stenosis in patients with coronary artery disease
W J Jean, I al-Bitar, D L Zwicke, et al.
Human Molecular Genetics
|
November 1, 1994
Mitochondrial DNA polymorphism in disease: a possible contributor to respiratory dysfunction
P Lertrit, R M Kapsa, M J Jean-Francois, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
A bioanalytical investigation on the exquisitely strong in vitro potency of the EGFR-DNA targeting type II combi-molecule ZR2003 and its mitigated in vivo antitumour activity
Nahid Golabi, Fouad Brahimi, Ying Huang, et al.
Annales De Dermatologie Et De Venereologie
|
January 30, 2010
[Cutaneous events during anti-TNF alpha therapy: a prospective observational study of 41 cases]
N Bonnet, S Guis, M-C Koeppel, et al.
La Revue De Medecine Interne
|
October 16, 2002
[Cutaneous vasculitis during pergolide mesylate treatment]
J Serratrice, B Granel, P Disdier, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 333) with videos related to
Sort By:
Page
of 34
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties
Qiyu Qiu, Fabienne Dudouit, Stephanie L Matheson, et al.
Journal of Vascular Surgery
|
November 1, 1994
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
K M Newman, J Jean-Claude, H Li, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
Suman Rao, Benoît Thibault, Lisa Peyrard, et al.
Chemical Biology & Drug Design
|
March 8, 2008
Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase
Anne-Laure Larroque, Brad Peori, Christopher Williams, et al.
Frontiers in Aging Neuroscience
|
December 21, 2020
Fornix Integrity Is Differently Associated With Cognition in Healthy Aging and Non-amnestic Mild Cognitive Impairment: A Pilot Diffusion Tensor Imaging Study in Thai Older Adults
Patcharaporn Srisaikaew, Nahathai Wongpakaran, Nicole D Anderson, et al.
Catheterization and Cardiovascular Diagnosis
|
May 1, 1994
High incidence of renal artery stenosis in patients with coronary artery disease
W J Jean, I al-Bitar, D L Zwicke, et al.
Human Molecular Genetics
|
November 1, 1994
Mitochondrial DNA polymorphism in disease: a possible contributor to respiratory dysfunction
P Lertrit, R M Kapsa, M J Jean-Francois, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
A bioanalytical investigation on the exquisitely strong in vitro potency of the EGFR-DNA targeting type II combi-molecule ZR2003 and its mitigated in vivo antitumour activity
Nahid Golabi, Fouad Brahimi, Ying Huang, et al.
Annales De Dermatologie Et De Venereologie
|
January 30, 2010
[Cutaneous events during anti-TNF alpha therapy: a prospective observational study of 41 cases]
N Bonnet, S Guis, M-C Koeppel, et al.
La Revue De Medecine Interne
|
October 16, 2002
[Cutaneous vasculitis during pergolide mesylate treatment]
J Serratrice, B Granel, P Disdier, et al.
Page
of 34